U19AR076725
Cooperative Agreement
Overview
Grant Description
Influence of inflammation-related genetic variants on PT treatment response in a population affected by CLBP.
Grant Program (CFDA)
Awarding Agency
Place of Performance
Pittsburgh,
Pennsylvania
15213
United States
Geographic Scope
Single Zip Code
Related Opportunity
Notes
Amendment Since initial award the End Date has been extended from 05/31/24 to 08/31/24 and the total obligations have increased 29% from $16,756,172 to $21,666,404.
University Of Pittsburgh - Of The Commonwealth System Of Higher Education was awarded
Cooperative Agreement U19AR076725
worth $21,666,404
from the National Institute of Neurological Disorders and Stroke in September 2019.
The grant
has a duration of 5 years and
was awarded through assistance program 93.279 Drug Abuse and Addiction Research Programs.
Status
(Ongoing)
Last Modified 9/5/23
Period of Performance
9/26/19
Start Date
8/31/24
End Date
Funding Split
$21.7M
Federal Obligation
$0.0
Non-Federal Obligation
$21.7M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U19AR076725
Transaction History
Modifications to U19AR076725
Additional Detail
Award ID FAIN
U19AR076725
SAI Number
U19AR076725-2388972124
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Other
Awarding Office
75NB00 NIH NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
Funding Office
75NQ00 NIH NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Performance District
PA-PA-12
Senators
Robert Casey
John Fetterman
John Fetterman
Modified: 9/5/23